Skip to main content
Equibles

VANGUARD PORTFOLIO MANAGEMENT LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 2100121 MALVERN, PA
Back to HALO Full portfolio

Position in HALO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$414,753,356
+$75,497,173 QoQ
Shares Held
5,299,008
+0.9% QoQ
Ownership
4.67%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#3
of 667 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

VANGUARD PORTFOLIO MANAGEMENT LLC holds $29,186,942,856 across 295 Biotechnology names. HALO ranks #24 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,878,987 $2,423,539,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,175,313 $1,979,934,668
3 ALNY
Alnylam Pharmaceuticals, Inc.
 6,538,390 $1,968,251,541
4 RVMD
Revolution Medicines, Inc.
 8,294,855 $1,553,460,444
5 INSM
INSMED Inc
 10,407,962 $1,109,696,908
6 MRNA
Moderna, Inc.
 15,581,313 $1,091,159,349
7 INCY
Incyte Corp
 7,791,091 $883,198,075
8 ROIV
Roivant Sciences Ltd.
 21,641,339 $765,886,987

All Filings in HALO

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $414,753,356 5,299,008
2026-03-31 $339,256,183 5,249,206